Skip to main content
. 2002 Nov 11;99(25):16168–16173. doi: 10.1073/pnas.242600099

Fig 4.

Fig 4.

Analysis of T cell infiltrate from tumor nodule harvested from patient 1017-2 after infusion of MART1-specific CD8+ T cell clones. Percentage of infused clone (tetramer+, CD8+ T cells) among all CD8+ T cells is displayed in the upper right quadrant. Significant infiltrate comprised of MART1-specific CD8+ T cells is seen in postinfusion tumor nodule (37.7%; A) compared with preinfusion nodule (0.0%; B) and postinfusion peripheral blood (0.8%; C) demonstrating preferential localization of infused clones to tumor site. Less than 0.2% of CD8 T cells in tumor nodule stain with an irrelevant tetramer (tyrosinase-peptide tetramer; D).